Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Cell International
Published in: Cancer Cell International 1/2020

Open Access 01-12-2020 | Hepatocellular Carcinoma | Retraction Note

Retraction Note to: Circular RNA ABCB10 promotes hepatocellular carcinoma progression by increasing HMG20A expression by sponging miR-670-3p

Authors: Yu Fu, Limin Cai, Xuexue Lei, Dunwei Wang

Published in: Cancer Cell International | Issue 1/2020

Login to get access

Excerpt

The Editor-in-Chief has retracted this article [1] due to lack of evidence that the study has received ethics approval. After publication it has come to the Editor’s attention that in the body of the article the authors state that their study was approved by the First Hospital of Jilin University Research Ethics Committee. However, in the Ethics declarations section, the authors state that their study was approved by the Ethics Committee of the Maternity and Child Care Center of Liuzhou. The authors have not provided documentation of approval from an ethics committee for this study. The authors have not responded to any correspondence regarding this retraction. …
Literature
1.
Metadata
Title
Retraction Note to: Circular RNA ABCB10 promotes hepatocellular carcinoma progression by increasing HMG20A expression by sponging miR-670-3p
Authors
Yu Fu
Limin Cai
Xuexue Lei
Dunwei Wang
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2020
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-020-01586-0

Other articles of this Issue 1/2020

Cancer Cell International 1/2020 Go to the issue

Primary research

FOXM1 modulates docetaxel resistance in prostate cancer by regulating KIF20A

Primary research

Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma

Primary research

Evaluation of the potential role of long non-coding RNA LINC00961 in luminal breast cancer: a case–control and systems biology study

Primary research

Sirtuin 1 inhibits lipopolysaccharide-induced inflammation in chronic myelogenous leukemia k562 cells through interacting with the Toll-like receptor 4-nuclear factor κ B-reactive oxygen species signaling axis

Primary research

MEX3A knockdown inhibits the development of pancreatic ductal adenocarcinoma

Primary research

Identification and validation of stromal-tumor microenvironment-based subtypes tightly associated with PD-1/PD-L1 immunotherapy and outcomes in patients with gastric cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits